The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

Research output: Contribution to journalComment/debateResearchpeer-review

  • Tobias W Klausen
  • Henrik Gregersen
  • Niels Abildgaard
  • Niels Frost Andersen
  • Ulf Christian Frølund
  • Peter Gimsing
  • Carsten Helleberg
  • Vangsted, Annette Juul
Original languageEnglish
JournalLeukemia
Volume33
Issue number2
Pages (from-to)546-549
Number of pages4
ISSN0887-6924
DOIs
Publication statusPublished - Feb 2019

    Research areas

  • Aged, Clinical Trials, Phase III as Topic/statistics & numerical data, Guideline Adherence, Humans, Multiple Myeloma/diagnosis, Patient Selection, Registries, Research Design/standards

ID: 235916826